Andreas Pinter

Andreas Pinter

Department Of Dermatology, Venereology And Allergology, University Hospital Frankfurt Am Main, Germany.

Direct Impact

Concepts for which Andreas Pinter has direct influence:

acne conglobata
single centre
pharmacokinetic profile
psoriasis vulgaris
pde-4 inhibitor
mc2 cream
inflammation nfkappab

External impact

Concepts related to the work of other authors for which Andreas Pinter has influence:

hidradenitis suppurativa
rifampicin therapy
oral clindamycin
modified sartorius
inflammatory comorbidities
reasonable alternative
systemic doxycycline

Prominent publications by Andreas Pinter

KOL-Index: 46 BACKGROUND: Tetracyclines and clindamycin plus rifampicin combination therapy are both considered first-line therapy in current hidradenitis suppurativa guidelines. However, evidence for their efficacy is drawn from small studies, often without validated outcomes. OBJECTIVE: To assess the 12-week efficacy of oral tetracyclines and a combination of clindamycin and rifampicin. METHODS: A ...
Known for
Tetracyclines Combination | Nodule Count | Included 283 | Therapy Hidradenitis
KOL-Index: 5
Known for
Lichen | Erfolgreicher Therapieversuch
KOL-Index: 2 Apremilast mediates its clinical effect through the cAMP-PKA-NFkappaB pathway which results in a clinical picture changes to a decrease of all signs of inflammation.Due to the NFkappaB mediated chronical inflammation in the pathogenesis of acne conglobata, a treatment with Apremilast seems to be an effective option.In this study, treatment with Apremilast (Otezla®) will be performed in ...
Known for
Effective Option | Concept Design | Conglobata Pde-4 | Effects Apremilast
KOL-Index: 2 This is a phase 2, open-label, single-group, multicentre trial in which the investigational product, MC2-01 cream, is investigated in adolescent subjects (age 12 to 16 years, 11 months) with clinically diagnosed extensive psoriasis vulgaris. Detailed Description The MC2-01 cream is designed for optimal patient satisfaction - it quickly absorbs into the skin leaving it nicely moisturized ...
Known for
Optimal Satisfaction | Trial Medication | Maximum Conditions

Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt am Main, Germany.

© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172